Great Novel Therapeutics Biotech & Medicals

TPEX:7427 Stock Report

Market Cap: NT$1.6b

Great Novel Therapeutics Biotech & Medicals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chia-Nan Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.8yrs
CEO ownership3.9%
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

Recent updates


CEO

Chia-Nan Chen

8.8yrs

Tenure

Dr. Chia-Nan Chen serves as Chairman and President of Great Novel Therapeutics Biotech & Medicals (formerly known as GNT Biotech & Medicals Corporation). In 2013, Dr. Chen was one of the founders of GNTbm....


Board Members

NamePositionTenureCompensationOwnership
Chia-Nan Chen
President & Chairman of the Board8.8yrsno data3.87%
NT$ 61.9m
Chung-Yang Huang
Directorno datano data3.11%
NT$ 49.7m
Hung-Jen Wu
Directorno datano data2.02%
NT$ 32.4m
Tonggui Chen
Supervisorno datano datano data
Gary T. Tseng
Director3.5yrsno datano data
Johnsea Chen
Independent Directorno datano datano data
Hung-hui Cheng
Independent Directorno datano datano data
Shang-Pwu Shia
Independent Directorno datano datano data
Hsiu-Chen Chiu
Independent Director1.8yrsno datano data

3.5yrs

Average Tenure

Experienced Board: 7427's board of directors are considered experienced (3.5 years average tenure).